RA CAPITAL MANAGEMENT, L.P. - Insider Non-Derivative Transactions at ARS Pharmaceuticals, Inc. (SPRY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 27, 2024, RA CAPITAL MANAGEMENT, L.P.'s relationship to ARS Pharmaceuticals, Inc. (SPRY) is Director,TenPercentOwner, and currently has 9,958,073 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SPRY insiders.
Data Source: SEC.
RA CAPITAL MANAGEMENT, L.P. - Insider Non-Derivative Transactions of SPRY Common Stock
RA CAPITAL MANAGEMENT, L.P. - Insider Non-Derivative Transactions at SPRY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 28, 2024 | P -- (Common Stock) | 505954 | 9.79 | 9958073 |
| Mar 27, 2024 | P -- (Common Stock) | 457745 | 9.55 | 9452119 |
| Mar 26, 2024 | P -- (Common Stock) | 437600 | 9.06 | 8994374 |